ScholarIQanswers from OpenAlex & ORCID
Dean Follmann
ResearcherPublications, citations & collaboration network
Dean Follmann is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dean Follmann have?
ScholarIQindexed works
Dean Follmann has 284 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dean Follmann have?
ScholarIQcitation count
Dean Follmann has 17,531 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dean Follmann?
ScholarIQh-index
Dean Follmann has an h-index of 56 in OpenAlex.
What is the i10-index of Dean Follmann?
ScholarIQi10-index
Dean Follmann has an i10-index of 146 in OpenAlex.
What is the ORCID of Dean Follmann?
ScholarIQorcid
The ORCID for Dean Follmann is on the source record.
What is the OpenAlex record for Dean Follmann?
ScholarIQopenalex
The OpenAlex for Dean Follmann is on the source record.
What are the most-cited papers on Dean Follmann?
ScholarIQmost cited works
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
Arie Katz, Sridhar Nambi, Kieren J. Mather, Alain Baron, Dean Follmann, Gail W. Sullivan, Michael J. Quon
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Britta Flach, Bob C. Lin, Sarah O’Connell, Charlene McDanal, Amanda Eaton, Marcella Sarzotti‐Kelsoe, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Chuong Huynh, Jacqueline M. Miller, Hana M. El Sahly, Lindsey R. Baden, Mira Baron, Luis de la Cruz‐Merino, Cynthia L. Gay, Spyros A. Kalams, Colleen F. Kelley, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajón, Dean Follmann, Rubén O. Donis, Richard A. Koup, Immune Assays Team§, Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team§, United States Government (USG)/CoVPN Biostatistics Team§
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson, Thomas Campbell, Jesse L. Clark, Lisa A. Jackson, Carl J. Fichtenbaum, Marcus Zervos, Bruce Rankin, Frank Eder, Gregory Feldman, C Kennelly, Laurie J. Han-Conrad, Michael Levin, Kathleen M. Neuzil, Lawrence Corey, Peter B. Gilbert, Holly Janes, Dean Follmann, Mary Marovich, Laura Polakowski, John R. Mascola, Julie E. Ledgerwood, Barney S. Graham, Allison August, Heather Clouting, Weiping Deng, Shu Han, Brett Leav, Deb Manzo, Rolando Pajón, F. Schödel, Joanne E. Tomassini, Honghong Zhou, Jacqueline M. Miller